Investigation of hand-foot syndrome (HFS) observed in pazopanib (P)-treated patients (pts) with renal cell carcinoma (RCC).
H. A. Ball
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Y. Lin
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Z. Xue
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
B. Suttle
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
C. Xu
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
L. Huang
Research Funding - GlaxoSmithKline
L. McCann
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
T. E. Hutson
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
C. N. Sternberg
Honoraria - GlaxoSmithKline
L. N. Pandite
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline